The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease

2022 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Garg, Pretty, et al. "The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease​." ​Molecular and Cellular Neuroscience, vol. 121, ​2022, , ​doi: 10.1016/j.mcn.2022.103746. 

Copy

Further links

Documents & Media

License

Usage license

Details

Authors
Garg, Pretty; Maass, Fabian; Sundaram, Sivaraj M.; Mollenhauer, Brit; Mahajani, Sameehan; van Riesen, Christoph; Kügler, Sebastian; Bähr, Mathias 
Issue Date
2022
Journal
Molecular and Cellular Neuroscience 
Project
EXC 2067: Multiscale Bioimaging 
Working Group
RG Bähr (Neurobiological Research Laboratory) 
ISSN
1044-7431
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media